Cardiac Arrhythmia Program
Cardiac arrhythmias
ResearchActive
Key Facts
About Current Surgical
Current Surgical is a private, pre-revenue medical device startup founded in 2016, building a foundational platform for the next generation of minimally invasive, digital surgery. Its core technology integrates AI-processed real-time imaging with precision focused ultrasound ablation in a closed-loop control system, initially targeting early-stage solid tumor ablation. The company has a clear multi-year pipeline to expand into cardiac, pain, and neurological markets, is backed by elite investors like True Ventures, and has secured non-dilutive funding from the NIH and NSF to advance its platform.
View full company profileTherapeutic Areas
Other Cardiac arrhythmias Drugs
| Drug | Company | Phase |
|---|---|---|
| nsPFA Navigation (Pulse Biosciences) | CardioNXT | Pre-clinical |
| Platform Extension (e.g., Cardioneuroablation) | inHEART | Development/Exploration |
| MicroPort EverPace™ PulseMagic™ TrueForce® PFA Catheter | MicroPort | NMPA Approved |
| Aveir DR Dual-Chamber Leadless Pacemaker | Abbott | Clinical Investigation |